Psychotropic PGx Panel for Drug Treatment Optimization [Test in Focus] - Insights
Ann Moyer, M.D., Ph.D. gives an overview of this new test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon other testing approaches, and what clinical action can...
Emergency/Overdose - Mayo Clinic Laboratories
Emergency/Overdose This test is intended to manage an apparent overdose, intoxicated patient, or determine if a specific set of symptoms might be due to the presence of drugs. This test is designed...
In this month’s “Hot Topic,” Robin Patel, M.D., discusses the FilmArray meningitis/encephalitis (ME) panel, describing the panel, her experience with it, and an algorithm for its use.
TPNUQ genotyping assay - Insights
Ann Moyer, M.D., Ph.D., discusses TPNUQ, Mayo Clinic Laboratories' genotyping test for identifying patients at risk for thiopurine toxicity. Used prior to therapy initiation, our assay evaluates for nuances in both TPMT and NUDT15, which...
Find out more about UBA1Q, a quantitative droplet digital polymerase chain reaction (ddPCR) assay that targets seven possible mutations that can occur in the UBA1 gene and help identify VEXAS syndrome.
https://www.mayocliniclabs.com/test-catalog/pdf-reports.php
MCL PDF Reports Values current as of May 5, 2025 Mayo Test ID Published Name PDF 2OHGP 2-Hydroxyglutaric Aciduria Gene Panel, Varies Supplemental 3MGAP 3-Methylglutaconic Aciduria Panel, Varies Supplemental ADPKP Focused Autosomal...
COVID-19 weekly news: April 4-10 2022 - Insights
Topic's Include: Testing wastewater for COVID-19: The clearest path to understanding community infection, and the latest advice about COVID-19 boosters.
Applying the Staffing-to-Workload Methodology: Identifying Daily Indirect Effort Needs - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, demonstrates how daily indirect effort tasks contribute to staffing plans and needs in the staffing-to-workload methodology.
New tests launched in March - Insights
In March 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Mayo Clinic Laboratory and Pathology Research Roundup: November 7, 2023 - Insights
This week's research roundup feature: Cytomegalovirus (CMV) is a significant cause of morbidity and mortality among immunocompromised hosts, including transplant recipients. Antiviral prophylaxis or treatment is used to reduce the incidence...